Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for COVID-19 Prevention in Nursing Homes (PREVICHARM)
NCT04400019Phase 3Unknown
- Sponsor
- Universidad de Málaga
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Universidad de Málaga. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04400019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400019.